Briefing: Key Facts About Medicare Drug Price Negotiation

The Medicare Drug Price Negotiation Program involves the federal government negotiating prices with pharmaceutical companies for certain high-cost medications.

This program specifically targets drugs covered under Medicare Part B and Part D, aiming to reduce expenses for both the government and beneficiaries.

The implications of this negotiation process could lead to significant shifts in drug pricing structures and healthcare expenditure, necessitating close monitoring of outcomes.